MONTEREY BIO ACQUISITION COR - COM (MTRY)

CUSIP: 61240F108

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
9,766,824
Share change
+9,545,596
Total reported value
$96,403,600
Price per share
$9.87
Number of holders
34
Value change
+$94,218,600
Number of buys
32

Quarterly Holders Quick Answers

What is CUSIP 61240F108?
CUSIP 61240F108 identifies MTRY - MONTEREY BIO ACQUISITION COR - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MONTEREY BIO ACQUISITION COR - COM (MTRY) as of Q4 2021

As of 31 Dec 2021, MONTEREY BIO ACQUISITION COR - COM (MTRY) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,766,824 shares. The largest 10 holders included Saba Capital Management, L.P., Karpus Management, Inc., ATW SPAC MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, D. E. Shaw & Co., Inc., Weiss Asset Management LP, Murchinson Ltd., BERKLEY W R CORP, Shaolin Capital Management LLC, and Polar Asset Management Partners Inc.. This page lists 34 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.